Compounded Sema Injectable denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for compounded sema injectable are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Compounded Semaglutide for Medical Necessity

A medical-necessity denial from Cigna means that Cigna's reviewers determined the submitted clinical information did not satisfy the coverage criteria in Cigna's medical policy for this drug class. For compounded semaglutide specifically, this denial is often layered: Cigna may apply medical-necessity criteria for GLP-1 agents generally (requiring diagnosis confirmation and prior-treatment history) while simultaneously applying a separate coverage position on compounded formulations. The medical-necessity basis targets whether the drug is clinically appropriate for this patient, not just whether the specific formulation is covered.

## Why This Is Appealable

Medical-necessity denials are the single most commonly overturned denial type on internal appeal because they are often issued after a paper review of incomplete records. When the prescriber submits a complete, well-organized clinical record with a thorough medical-necessity letter directly addressing each of Cigna's coverage criteria, the denial rate drops substantially. The appeal is an opportunity to reframe the case with the full clinical story that the initial authorization request may not have conveyed.

## The Federal Appeal Framework

• Internal appeal (Level 1): File under ERISA Section 503 or ACA Section 2719 within the deadline stated in the denial notice. Cigna must issue a pre-service decision within 30 days (or 60 days for post-service). Request a copy of the specific criteria Cigna applied.
• Peer-to-peer review: Before or alongside the formal appeal, request a peer-to-peer discussion between the prescriber and Cigna's medical director. Many medical-necessity denials are reversed at this stage.
• External review: If the internal appeal is denied, request independent external review under ACA Section 2719 within approximately four months. External reviewers assess whether the treatment meets generally accepted standards — not just Cigna's proprietary criteria.
• Expedited option: Available if standard timelines pose a clinical risk.

## Documentation to Gather

• Diagnosis confirmation: Chart notes and lab or imaging records confirming the diagnosis (e.g., type 2 diabetes with inadequate glycemic control, or obesity with qualifying comorbidities) and its severity.
• Prior treatment history with outcomes: A chronological list of all relevant prior medications tried, including dates started and stopped, dosing regimen, and documented reason for discontinuation (inadequate efficacy, intolerance, contraindication) — matched against Cigna's step-therapy requirements.
• Clinical severity per the chart: Body weight trend, relevant metabolic markers over time, documented comorbidities, and functional impact — all drawn from the chart, not stated as general claims.
• Prescriber medical-necessity letter: A structured letter from the treating clinician that quotes each of Cigna's coverage criteria, then answers each criterion with a specific citation from the patient's chart. This is the single most important document in any medical-necessity appeal.
• Applicable guideline organization reference: The prescriber's letter should reference the relevant major guideline-issuing organization (e.g., American Diabetes Association, Obesity Medicine Association, or Endocrine Society) for the clinical standard being applied — without citing specific numbers from those guidelines.

## Criteria-Mapping Structure

Obtain Cigna's current medical policy for GLP-1 receptor agonists. For every criterion, map it to chart evidence:

| Cigna Coverage Criterion | Chart Evidence | |---|---| | Qualifying diagnosis confirmed | Diagnosis codes, chart documentation, lab records | | Required prior therapies tried and failed | Medication history with dates, outcomes, reason stopped | | Prescriber specialty/qualifications | Prescriber's credentials and treating role | | Monitoring and follow-up plan | Prescriber's treatment plan in the chart |

Request the specific rationale and criteria version Cigna applied from the denial letter — you have a legal right to this under ERISA, and it ensures your appeal addresses the exact basis for denial.